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Introduction
Symptoms are conventionally classified as either
psychological (for example, depressed mood, anxiety,
guilt) or physical. Physical symptoms constitute bodily
sensations such as pain, dizziness, palpitations, and
fatigue. Such symptoms are commonly referred to as
‘physical’ by physicians who care predominantly for
medical disorders, and ‘somatic’ by psychiatrists and
psychologists in the context of mental disorder.
Although the terms ‘physical’ and ‘somatic’ are inter-
changeable, it is inaccurate to equate physical
symptoms with physical (medical) disorders because
many patients with physical disorders (such as hyper-
tension, well-controlled diabetes mellitus, stable
coronary artery disease) are asymptomatic, and many
patients with physical symptoms do not have a
medical disorder that accounts for the presence and/or
severity of their physical symptoms. 
The co-occurrence of physical and psychiatric
disorders has been a topic of increasing interest; it has
been well established that there is at least a twofold
greater risk of experiencing a depressive or anxiety
disorder in patients with concomitant cardiovascular
disease, neurological disorders, cancer, diabetes, HIV
disease, and many other physical disorders. However,
the topic of ‘medical co-morbidity’ will not be the
focus of this paper. Rather, the relationship between
somatic symptoms and psychiatric disorders, especially
depression and anxiety, will be reviewed. In addition,
the epidemiology and management of somatic
symptoms will be addressed.
Prevalence and prognosis of somatic symptoms
Somatic symptoms account for over 50% of all outpa-
tient visits, or an estimated 400 million clinic visits in
the US alone each year (Schappert, 1992). This
includes visits for pain, headache, fatigue and dizziness
(Figure 1) as well as other physical complaints. Indeed,
somatic symptoms in the general population are
ubiquitous. An estimated 80% of individuals will
experience one or more symptoms in any given month
(Reidenberg et al., 1968; Kroenke et al., 1990; Green et
al., 2001). These symptoms are often self-limited,
because only about one in four patients seeks healthcare
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for their symptoms (Green et al., 2001). Besides the
severity or duration of a symptom (or symptoms),
specific concerns and expectations as well as psycho-
logical factors are important reasons why patients seek
health care for their somatic symptoms (Jackson and
Kroenke, 2001; Kroenke, 2001).
The prognosis for most patients is favourable (Brody
et al., 1989; ; Speckens et al., 1996; Marple et al.,
1997; Kroenke and Jackson, 1998; Jackson and
Passamonti, 2001). Approximately 75% of patients
report resolution or improvement of their somatic
symptoms within a few weeks of seeing a health care
provider. Even in those patients whose symptom has
been present for a year or more, 50% report
improvement within two weeks of seeking care
(Kroenke and Jackson, 1998). 
As 75% of patients improve within several weeks,
this suggests that approximately 25% of patients report
persistence of their symptoms (unchanged or worse).
This proportion has been consistent across multiple
studies as shown in Table 1. Interestingly, it appears
that the persistence rate of symptoms holds constant at
25%, with follow-up intervals as long as five years
(Jackson and Passamonti, 2001). Thus, although the
majority of patients with somatic symptoms improve,
an important minority suffers from chronic or
recurrent symptoms. While most individual types of
somatic symptoms have a persistence rate of 20% to
25%, some symptoms such as back pain, headache, and
musculoskeletal complaints have an even higher one-
year persistence rate of between 35% and 45% (Khan
et al., 2000; Gureje and Simon, 1999).
Medically unexplained symptoms
At least 33% of somatic symptoms in primary care and
population-based studies are ‘medically unexplained’
(Khan et al., 2000; Kroenke and Mangelsdorff, 1989;
Kroenke and Price, 1993; Kroenke et al., 1994; Marple
et al., 1997). As shown in Table 2, the proportion
ranges from 20% to 74%, depending on the method
used for classifying a symptom as medically
unexplained. The classification method used in the
two outlier studies makes it likely that 74% is an
overestimate and 20% is an underestimate. The fact
that three other studies using different samples and
methods each concluded that one-third of somatic
symptoms are medically unexplained makes this a
reasonable estimate.
It appears that medically unexplained symptoms are
also prevalent among patients referred to sub-specialty
clinics. The proportion of patients with medically
unexplained symptoms, attending seven different types
Figure 1. Estimated number of clinic visits due to somatic symptoms in the US each year (Shappert 1992).
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of medical and surgical sub-specialty clinics in the UK,
has been evaluated (Reid et al., 2001). As the analysis
was limited to ‘frequent attenders’, the proportions
may overestimate the prevalence among all clinic
attenders. Nonetheless, the proportion of frequent
attenders with medically unexplained symptoms was
54% in gastroenterology clinics, 50% in neurology
clinics, 34% in cardiology clinics, 33% in rheuma-
tology clinics, 30% in orthopedics clinics, 27% in
otolaryngology clinics, 17% in general surgery and
gynaecology clinics, and 15% in pulmonary clinics
(Reid et al., 2001).
Functional symptom syndromes
Many patients present with individual somatic
symptoms, such as back pain, headache, dizziness, and
dyspnea. However, others present with common
functional syndromes manifested by constellations of
somatic symptoms, such as irritable bowel syndrome
(IBS), fibromyalgia (FM), chronic fatigue syndrome
(CFS), temporomandibular disorder (TMD), and the
highly controversial multiple chemical sensitivity
(MCS). The overlap between functional syndromes in
terms of symptoms, functional impairment, psychiatric
co-morbidity and response to generic treatments has
previously been summarized (Wessely et al., 1999;
Barsky and Borus, 1999). Recently, 53 studies that
examined the co-occurrence of two or more syndromes
in patient groups have been reviewed (Aaron and
Buchwald, 2001). The co-occurrence rate (overlap)
was 35% to 70% for FM and CFS, 32% to 80% for FM
and IBS, 58% to 92% for CFS and IBS, 33% to 55%
for FM and MCS, and 30% to 67% for CFS and MCS.
The degree of overlap is not surprising considering
how these functional syndromes are diagnosed, which
is predominantly or exclusively on the basis of somatic
symptoms. The prevalence of individual symptoms
such as fatigue, sleep disturbance, musculoskeletal
Table 1. Persistence of somatic symptoms in primary care patients
Author N Study sample Symptom persistence by follow-up interval
1–2 weeks 3 months 1 year 5 year
Marple 328 Somatic symptom as presenting complaint in primary care 22% – – –
Kroenke
Jackson 500 Somatic symptom as presenting complaint in primary care 29% 21% – 24%
Brody 117 Minor acute somatic complaint in primary care 27% – – –
Speckens 100 Medically unexplained somatic symptom in primary care – – 24% –
Table 2. Proportion of somatic symptoms that are medically unexplained
Lead author N Study sample and design Method for classifying as medically unexplained Medically 
unexplained
Kroenke 1000 Primary care chart review study One physician chart auditor using implicit criteria 74%
Khan 450 Primary care chart review study Two physician chart auditors using explicit criteria; 
interrater reliability also assessed 34%
Kroenke 13,328 Population-based survey Structured lay interview of subjects using 
Diagnostic Interview Schedule 35%
Marple 338 Primary care prospective Clinical judgment of patient’s primary care physician 33%
cohort study
Kroenke 1000 Primary care survey Clinical judgment of patient’s primary care physician* 20%
* Certain somatic symptoms were not counted as ‘medically unexplained’ if they were part of diagnostic criteria for a
depressive disorder (such as fatigue or insomnia) or an anxiety disorder (such as chest pain or palpitations in patient with
panic disorder), and patient-met criteria for that particular depressive or anxiety disorder.
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pains, headache, and gastrointestinal complaints is
high across all syndromes (Gardner et al., in press). 
Depression and anxiety
The majority (70–90%) of patients with depression or
anxiety who present in primary care complain of
somatic symptoms rather than volunteering psycho-
logical symptoms such as ‘I’m depressed’, or ‘I’ve been
feeling anxious’ (Simon et al., 1999). On the other
hand, most patients with a depressive or anxiety
disorder will admit to psychological symptoms if
specifically asked about them (Whooley et al., 1997;
Simon et al., 1999; Williams et al., 1999). Thus,
somatic symptoms present an ‘opening’ for the primary
care clinician to inquire about co-existing psycho-
logical distress.
Several aspects related to somatic symptoms should
heighten the clinician’s suspicion of a depressive or
anxiety disorder. First, symptoms that remain
medically unexplained after initial evaluation carry a
higher risk of psychiatric co-morbidity. Notably, the
specific type of somatic symptom does not matter.
Approximately 50% to 75% of patients with medically
unexplained symptoms have a depressive disorder, and
40% to 50% have an anxiety disorder, whether the
symptom is pain, fatigue, disturbed sleep, a gastroin-
testinal complaint, or any other unexplained somatic
symptom (Kroenke et al., 1994).
The number of somatic symptoms is also a powerful
marker of psychological co-morbidity. As shown in
Table 3, there is a powerful relationship between the
number of somatic symptoms and the likelihood of a
concomitant depressive or anxiety disorder (Kroenke
et al., 1994; Kroenke and Jackson, 1997). It might be
useful to think of the somatic symptom count as a ‘sed
rate’ for potential psychopathologic inflammation.
Analogous to the erythrocyte sedimentation rate
(ESR), which is a sign of physical inflammation, the
somatic symptom count is non-specific, but the higher
the latter, the greater the likelihood of a patient
meeting criteria for a coexisting (and potentially
treatable) depressive or anxiety disorder.
Several other predictors of depression and anxiety
have been revealed in a series of studies and are
captured in the ‘S4’ model (Kroenke et al., 1997;
Jackson et al., 1998; Jackson et al., 2001). One of the
predictors – a high somatic symptom count – has
already been mentioned. The other three predictors
are recent stress, low self-rated health, and high
severity of the patient’s presenting somatic symptom.
As shown in Table 4, the presence of any of these four
predictors individually increases the risk of an under-
lying depressive or anxiety disorder, and the likelihood
of these disorders increases incrementally with the
number of predictors.
The clinician’s perception that the patient
encounter is difficult is also a surprisingly good
predictor of co-morbid depression or anxiety. About
one out of every six outpatient visits is considered
difficult by the primary care physician, and patients
whose visits are rated as difficult are two to three times
more likely to have a depressive or anxiety disorder
(Jackson and Kroenke, 1999; Hahn et al., 1996; Hahn
2001). Moreover, difficult encounters are strongly
associated with medically unexplained symptoms as
well as high somatic symptom counts. Physicians’
attitudes towards caring for patients with psychosocial
problems may be one potentially modifiable factor:
physicians with poor attitudes find 23% of their
patient visits difficult, whereas physicians who feel
more positive about evaluating and managing
psychosocial problems find only 8% of their patient
visits difficult (Jackson and Kroenke, 1999). A high
case mix of complex psychosocial problems is one
factor associated with career dissatisfaction among
primary care physicians (Wetterneck et al., 2002), and
improving physician training in the management of
depression, anxiety and other mental disorders may
therefore be valuable for both improved care of
patients with somatic complaints, as well as dimin-
ished physician frustration.
High utilization of health care services (for
example, frequent clinic visits) is another predictor of
psychological distress (Katon et al., 2001). Medical co-
morbidity also increases the risk of depression and
anxiet; these include the ‘three Cs’ (cardiovascular
disease, central nervous system disorders, and cancer),
diabetes, HIV disease and numerous other physical
conditions (Cassem, 1995). Table 5 summarizes some
of the factors that should increase clinical suspicion of
depression or anxiety in patients presenting with
somatic symptoms.
Some argue that routine screening for depression is
warranted in primary care (US Preventive Services Task
Force, 2002). However, the large volume of patients
seen, short appointments, and other ‘competing
demands’ make screening of every single patient poten-
tially burdensome (Klinkman, 1997; Williams, 1998).
Patients presenting with somatic complaints
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To reduce the number of patients screened and to lessen
the number of false positives, a case-finding approach in
which patients at greater risk are selectively evaluated is
an attractive option. This can still be done efficiently
because it has been shown that a single question about
depressed mood identifies 85% and 90% of patients
with major depression, and a second question about
anhedonia may increase the sensitivity to 95%
(Whooley et al., 1997; Williams et al., 1999). Patients
who screen positive can have the severity of their
depression graded with any number of simple instru-
ments (Mulrow et al., 1995; Williams et al., 2002).
Screening for depression is also warranted in
patients with persistent or unexplained somatic
symptoms who are seen in sub-specialty clinics.
Studies in patients newly referred to gastroenterology,
rheumatology, and neurology clinics have shown a
prevalence of depression of 25–30% (O’Malley et al,
1998a,b; Ekstrand et al., 2000). In these same studies,
depressed patients were only 25% as likely to have a
physical disorder diagnosed by the sub-specialist. Thus,
screening for depression may be more cost-effective
than many of the expensive diagnostic tests and proce-
dures often performed in patients with persistent and
unexplained somatic symptoms.
Management of somatic symptoms in primary care: a
stepped care approach
An algorithm that uses a stepped care approach for
managing somatic symptoms in primary care is illus-
trated in Figure 2. It is clinically useful to think of
patients initially presenting with somatic complaints
as falling into one of three categories:
• acutely serious – <5% of patients;
• minor and self-limited – 70% to 75% of patients;
• persistent (either chronic or recurrent) – 20% to
25% of patients.
As reviewed earlier in this paper, the evidence
supporting the proportion of patients falling into the
last two categories is fairly strong. Although
the epidemiology of ‘acutely serious’ symptoms has
been less well studied, it is probable that this category
represents less than 5% of all somatic symptoms
presenting in primary care – a number derived partly
from clinical experience but mainly by subtracting the
last two categories.
Step 1
Certain symptoms are occasionally acutely serious
(chest pain, dyspnea, new abdominal pain), whereas
others are seldom acutely serious (back pain,
headache, fatigue, dizziness). The presence or absence
of other ‘red flags’ on history or physical examination
typically dictates whether immediate diagnostic evalu-
ation is warranted. For the majority of primary care
patients with somatic symptoms, a focused history and
physical examination provides most of the diagnostic
and prognostic information (Kroenke, 2001). Follow-
up is preferable to an initial and expensive work-up; a
‘waiting period’ of two to six weeks can clarify whether
the symptom will be self-limited or persistent. The fear
of missing an occult but serious medical diagnosis is
Table 3. Relationship between somatic symptom count and likelihood of a depressive or anxiety disorder in primary care
patients
Number of somatic Study A (Kroenke) Study B (Kroenke) 
symptoms* (N = 1000) (N = 499)
N % Mood disorder % Anxiety disorder N % Mood or anxiety disorder 
0–1 215 1% 2% 106 4%
2–3 225 7% 12% 131 18%
4–5 191 13% 23% 129 31%
6–8 230 30% 44% 96 52%
≥9 139 48% 60% 37 78%
* Number of symptoms that the patient reports being ‘bothered a lot’ by in the past month selected from the PRIME-MD
checklist of 15 somatic symptoms.
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Table 5. Predictors of depression or anxiety in patients with somatic symptoms
Symptom characteristics
• Medically unexplained
• Multiple somatic symptoms
• Persistent/chronic (possibly)
S4 model predictors (the three predictors, besides multiple somatic symptoms)
• Stress – current
• Self-reported health is rated low
• Severity of symptom is rated high
Difficult encounter (as rated by clinician)
High utilization of health services (e.g., frequent clinic attender)
greatly overestimated. Studies of specific physical
symptoms as well as somatic symptoms in general have
shown that the physician’s initial judgement is quite
accurate, and that serious diseases thought unlikely at
the index visit rarely emerge with long-term follow up
(Kroenke, 1997, 2001; Khan et al., 2000).
In lieu of costly testing or referral, there are several
things the physician can do at the index visit.
Reassurance itself may be therapeutic in some patients
(Thomas, 1987). A more targeted type of reassurance
is to identify and address the patient’s symptom-
specific concerns and expectations, which commonly
Table 4. S4 Model: type and number of predictors of depressive or anxiety disorders: odds and ratio percentages
Variable Study A [Kroenke] Study B [Jackson] Study C [Jackson]
Number of subjects 500 250 185
Study population Primary care patients presenting Primary care patients presenting  New patients referred to 
with somatic complaints with somatic complaints rheumatology clinic
Individual predictor* Odds ratio for depressive or anxiety disorder †
Stress in past week 4.9 6.7 3.3
Symptom count >5 3.1 4.0 4.5
Self-rated health as low 2.7 2.2 3.4
Severity of symptom >5 2.0 1.2 1.6
Number of predictors Percentage with depressive or anxiety disorder
0 8 2 0
1 16 19 16
2 43 39 37
3 69 72 70
4 94 – 94
* The four S4 predictors are (1) recent stress (yes/no); (2) symptom count >5 on PRIME-MD checklist of 15 somatic
symptoms; (3) self-rated overall health of poor or fair on a 5-point scale (excellent, very good, good, fair, poor); (4) self-rated
severity of presenting somatic symptom of >5 on 0 (none) to 10 (unbearable) scale.
† All odds ratios are significant (ie, lower bounds of 95% confidence interval exceeds 1.0) except for severity of symptom in
Study B.
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include an explanation of the symptom’s cause and
prognosis, as well as a desire for specific physician
actions such as medication prescribing, test ordering,
sub-specialty referral, or administrative actions.
Studies have shown that addressing such expectations
is both efficient and effective (Jackson et al., 1999;
Jackson and Kroenke, 2001; Rao et al., 2000). Two
simple questions are: ‘was there anything else you were
worried about?’ and ‘was there anything else you
thought might be helpful?’ There are also pharmaco-
logical and non-pharmacological therapies that can be
provided for certain types of somatic symptoms in
patients whose symptoms have been particularly
bothersome, such as simple analgesics for pain, acid
suppressants for dyspepsia, gentle bowel medications
for constipation, sleep hygiene for insomnia, exercise
for back pain and fatigue, and habituation exercises or
meclizine for vertigo.
Step 2
Screening for depression and anxiety is certainly
warranted in those patients whose somatic symptoms
persist at two to six weeks’ follow-up and in whom a
specific, treatable medical diagnosis has not been
established. In fact, psychological screening may be
warranted at the index visit for those patients in whom
predictors are present (Table 5) or if, for other reasons,
the clinician suspects depression, anxiety or other
psychological factors are causing or contributing to the
patient’s somatic symptoms. Ideally, one would screen
for depression and possibly anxiety in all patients with
somatic symptoms at the index visit, but this is often
Figure 2. Stepped care approach to managing somatic symptoms in primary care.
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not feasible due to the competing demands of primary
care (Klinkman, 1997; Williams, 1998). The Patient
Health Questionnaire (PHQ) is one brief measure that
makes criteria-based diagnoses of depressive, anxiety,
somatoform, alcohol and eating disorders (Spitzer et
al., 1999). If evaluation of depression is the primary
aim, the nine-item depression module (PHQ-9) alone
can be used as a diagnostic and monitoring tool
(Kroenke et al., 2001). There are numerous other
instruments that have similar operating characteristics
for evaluating depression (Mulrow et al., 1995;
Whooley et al., 1997; Williams et al., 2002).
Should a depressive or anxiety disorder be
diagnosed, antidepressants as well as psychotherapy,
alone or in combination, are effective treatments.
What may be less well known is the efficacy of these
treatments for functional somatic syndromes. A series
of meta-analyses has recently documented the efficacy
of antidepressants in patients with IBS, FM, migraine
and tension headache, lower back pain, and several
other somatic symptoms or syndromes (O’Malley et
al., 1999, 2000; Jackson et al., 2000; Tomkins et al.,
2001; Salerno et al., 2002). Regardless of the type of
syndrome, patients were two to three times more likely
to respond to an antidepressant than a placebo. While
only 25% of the trials evaluated depression, it
appeared in this subset of studies that somatic
symptom improvement occurred independently from
an improvement in depression (O’Malley et al., 1999).
The majority of trials have been conducted with
tricyclic antidepressants, so the efficacy of newer
antidepressants for somatic syndromes is less clear.
Although not conclusive, it does appear that tricyclics
may be somewhat more effective for pain syndromes
than selective serotonin reuptake inhibitors. There is
preliminary evidence indicating that dual reuptake
antidepressants, which inhibit both norepinephrine
and serotonin receptors, may be beneficial in reducing
pain, although clinical trials are needed. 
The use of antidepressants for treating functional
somatic syndromes has limitations. Discontinuation
rates may be higher because of a heightened sensitivity
to somatic side effects – a ‘nocebo’ effect (Barsky et al.,
2002) – as well a causal attribution that is somatic and
rejects anything suggesting a psychological etiology
(‘my symptoms are physical; they are not in my head’).
Also, symptom reduction rather than total remission is
the most common therapeutic response. Further, most
trials have been short-term, and the long-term efficacy
of antidepressants for the treatment of chronic somatic
syndromes is not well established. Finally, as there are
evidence-based non-psychological treatments for some
functional syndromes (Leventhal, 1999; Jaiwala et al.,
2000), antidepressants can often be reserved as
adjunctive rather than primary treatment.
A recent review of 31 controlled trials of cognitive-
behavioural therapy (CBT) for somatic symptoms and
functional syndromes documents the efficacy of CBT
in the treatment of back pain, chest pain, IBS, CFS,
somatization, and other selected somatic symptoms
(Kroenke and Swindle, 2000). As few as five sessions
of group therapy and interventions proved efficacious,
and in some studies, benefits were sustained for up to
12 months. As with antidepressants, the benefits of
CBT did not seem to be entirely mediated through
amelioration of psychological distress. Finally, a
recent meta-analysis of 244 studies examining the role
of psychological factors in IBS, non-ulcer dyspepsia,
FM, and CFS found that depression and anxiety
accounted for part but not all of the symptomatology
in these functional somatic syndromes (Henningsen
et al., in press).
Step 3
Individuals with persistent somatic symptoms, who
are either not covered by Steps 1 and 2 or who fail to
respond to the suggested treatment strategies,
represent a heterogeneous group of patients.
Predisposing or maintaining factors can include (but
are not limited to): somatoform disorders such as
somatization disorder and hypochondriasis; person-
ality disorders; past or current history of sexual or
physical abuse; psychosocial reasons such as inter-
personal conflict, job dissatisfaction, and disability or
compensation-seeking behaviour; and opioid-
dependent chronic pain. In addition to the
identification of these or other contributing factors,
management includes: regular time-limited visits with
a primary care physician; avoidance of unnecessary
testing, procedures, and referrals; individual or group
programmes for self-management of, and coping with,
chronic symptoms; and complementary medical
therapies that are evidence based for certain somatic
symptoms (for example, chiropractic and acupuncture
for certain pain conditions).
Conclusion
Somatic symptoms account for over half of all outpa-
tient medical visits. Such symptoms are medically
unexplained 33% of the time, and are chronic or
Patients presenting with somatic complaints
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recurrent in 25% of patients. Medically unexplained,
persistent or multiple somatic symptoms should
heighten a physician’s clinical suspicion of a co-morbid
and potentially treatable depressive or anxiety disorder.
Other predictors of depression or anxiety include recent
stress, poor self-rated health, high symptom severity,
perception by the physician of a difficult patient
encounter, repeated clinic visits, and other chronic
medical disorders. Certain somatic symptoms and
functional somatic syndromes may respond to antide-
pressants and CBT, even in the absence of psychiatric
co-morbidity. A stepped care approach may improve the
care of patients with somatic symptoms, reduce health
care costs, and enhance physician satisfaction. 
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